Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers.
Mouri O, Melenotte C, Guéry R, Cotteret C, Schweitzer-Chaput A, Perignon A, Thellier M, Bourrat E, Kaguelidou F, Siriez JY, Malvy D, Gangneux JP, Duvignaud A, Ravel C, Cisternino S, Ransom J, Caumes E, Lortholary O, Grogl M, Buffet P. Mouri O, et al. Among authors: schweitzer chaput a. PLoS Negl Trop Dis. 2023 Aug 10;17(8):e0011492. doi: 10.1371/journal.pntd.0011492. eCollection 2023 Aug. PLoS Negl Trop Dis. 2023. PMID: 37561802 Free PMC article.
Refining the delivery and therapeutic efficacy of cetuximab using focused ultrasound in a mouse model of glioblastoma: An 89Zr-cetuximab immunoPET study.
Porret E, Kereselidze D, Dauba A, Schweitzer-Chaput A, Jegot B, Selingue E, Tournier N, Larrat B, Novell A, Truillet C. Porret E, et al. Among authors: schweitzer chaput a. Eur J Pharm Biopharm. 2023 Jan;182:141-151. doi: 10.1016/j.ejpb.2022.12.006. Epub 2022 Dec 15. Eur J Pharm Biopharm. 2023. PMID: 36529256
Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using 89Zr-cetuximab.
Tran VL, Novell A, Tournier N, Gerstenmayer M, Schweitzer-Chaput A, Mateos C, Jego B, Bouleau A, Nozach H, Winkeler A, Kuhnast B, Larrat B, Truillet C. Tran VL, et al. Among authors: schweitzer chaput a. J Control Release. 2020 Dec 10;328:304-312. doi: 10.1016/j.jconrel.2020.08.047. Epub 2020 Aug 27. J Control Release. 2020. PMID: 32860928